Observational studyArthritis care & research2025
Screening for Social Determinants of Health in Patients With Systemic Lupus Erythematosus: A Point-of-Care Feasibility Study.
Observational study in Arthritis care & research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveSocial determinants of health (SDoH) can impact outcomes but are not routinely screened for in US outpatient rheumatology clinics. This study determined the feasibility of routine point-of-care SDoH screening among patients with systemic lupus erythematosus (SLE) and associated barriers and facilitators at the physician, care team, and patient levels.
methodsThis observational, prospective, mixed-methods pilot study (GSK Study 219011) conducted in two large academic tertiary lupus clinics in the United States screened adults with SLE for SDoH over two weeks (institution 1, July to August 2023) and seven weeks (institution 2, August to October 2023). Patient demographics and patient-reported responses to questions covering up to eight SDoH domains chosen by participating institutions were collected, and an optional patient experience survey was conducted afterward. Participating physicians and care teams were asked questions on screening implementation, tool usability and comprehension, clinician acceptance, and facilitators of use. Transcripts were analyzed using thematic analysis.
resultsThe study included 69 patients with SLE across both institutions; 65 completed the patient experience survey. SDoH screening was successfully implemented with minimal disruption to clinical workflow and was viewed as valuable by physicians, care teams, and patients. Reported facilitators to successful SDoH screening included institutional leadership buy-in to address health equity and a brief screening tool format (five minutes or less). Barriers included limited resources and insufficient time or training.
conclusionWith an appropriately resourced and trained care team, successful routine SDoH screening in lupus clinics is feasible, valuable to clinicians and care teams, and effective for connecting patients to needed social resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.